HCPCS Level IIdrugActive
J9036
Inj. belrapzo/bendamustine
BETOS: O1D
Effective: 2019-07-01
Description
Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Bendamustine Hydrochloride
Manufacturer
Baxter Healthcare Corporation
HCPCS Dosage
1 MG
Billing Units
100.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.